KPNB1 and COVID-19: It will be of great interest to await and analyse the outcome of currently ongoing clinical trials targeting the KPNA/KPNB1 interface as a strategy to combat several types of cancer such as leukaemia and glioblastoma, as well as viral infections including Dengue fever and COVID-19.196